BlackRock Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.56M | Sell |
409,177
-2,095
| -0.5% | -$7.96K | ﹤0.01% | 2388 |
|
|
2016
Q3 | $3.69M | Buy |
411,272
+15,232
| +4% | +$136K | ﹤0.01% | 1703 |
|
|
2016
Q2 | $2.79M | Buy |
396,040
+45,768
| +13% | +$322K | ﹤0.01% | 1859 |
|
|
2016
Q1 | $2.98M | Buy |
350,272
+27,353
| +8% | +$232K | ﹤0.01% | 1729 |
|
|
2015
Q4 | $4.24M | Sell |
322,919
-12,513
| -4% | -$164K | 0.01% | 1502 |
|
|
2015
Q3 | $1.23M | Sell |
335,432
-65,099
| -16% | -$238K | ﹤0.01% | 2449 |
|
|
2015
Q2 | $2.31M | Buy |
400,531
+27,202
| +7% | +$157K | ﹤0.01% | 2111 |
|
|
2015
Q1 | $2.18M | Buy |
373,329
+13,803
| +4% | +$80.6K | ﹤0.01% | 1954 |
|
|
2014
Q4 | $2.82M | Buy |
359,526
+191,521
| +114% | +$1.5M | ﹤0.01% | 1771 |
|
|
2014
Q3 | $825K | Buy |
168,005
+2,603
| +2% | +$12.8K | ﹤0.01% | 2643 |
|
|
2014
Q2 | $1.02M | Sell |
165,402
-8,841
| -5% | -$54.6K | ﹤0.01% | 2578 |
|
|
2014
Q1 | $932K | Buy |
174,243
+11,486
| +7% | +$61.4K | ﹤0.01% | 2535 |
|
|
2013
Q4 | $851K | Sell |
162,757
-2,403
| -1% | -$12.6K | ﹤0.01% | 2594 |
|
|
2013
Q3 | $912K | Buy |
165,160
+9,442
| +6% | +$52.1K | ﹤0.01% | 2497 |
|
|
2013
Q2 | $394K | Buy |
+155,718
| New | +$394K | ﹤0.01% | 2966 |
|